Editorial: Nanoparticle-Mediated Signaling Rewiring and Reprogramming of Immune Responses

Abstract

Recent advances on the molecular mechanisms that control immune cells are at the core of the development of better immunomodulatory therapies. For example, these mechanisms may enable T cell manipulation interventions to treat and prevent autoimmune disease by rewiring T cells towards an anti-inflammatory phenotype. Indeed, it has been recently reported that metabolic sensing in immune cells is coupled to signal transduction pathways that control cell fate.